首页    期刊浏览 2024年11月29日 星期五
登录注册

文章基本信息

  • 标题:Exploring the Feasibility of Combining Chronic Disease Patient Registry Data to Monitor the Status of Diabetes Care
  • 本地全文:下载
  • 作者:Angela M. Kemple ; Noelle Hartwick ; Marilyn H. Sitaker
  • 期刊名称:Preventing Chronic Disease
  • 印刷版ISSN:1545-1151
  • 出版年度:2008
  • 卷号:05
  • 期号:04
  • 出版社:Centers for Disease Control and Prevention
  • 摘要:

    Introduction
    To provide direction and to support improvements in diabetes care, states must be able to measure the effectiveness of interventions and gain feedback on progress. We wanted to know if data from multiple health clinics that are implementing quality improvement strategies could be combined to provide useful measurements of diabetes care processes and control of intermediate outcomes.

    Methods
    We combined and analyzed electronic patient health data from clinic sites across Washington State that used the Chronic Disease Electronic Management System (CDEMS) registry. The data were used to determine whether national and state objectives for diabetes care were met. We calculated the percentage of patients that met standards of care in 2004.

    Results
    The pooled dataset included 17,349 adult patients with diabetes from 90 clinics. More than half of patients were above recommended target levels for hemoglobin A1c testing, foot examination, hemoglobin A1c control, and low-density lipoprotein cholesterol control. Fewer patients met recommendations for nephropathy assessment, eye examinations, and blood pressure control. In terms of meeting these standards, rates of diabetes care varied across clinics. CDEMS rates of care were compared with those reported by other data sources, but no consistent pattern of similarities or differences emerged.

    Conclusion
    With committed staff time, provider support, and resources, data from clinical information systems like CDEMS can be combined to address a deficiency in state-level diabetes surveillance and evaluation systems — specifically, the inability to capture clinical biometric values to measure intermediate health outcomes. These data can complement other surveillance and evaluation data sources to help provide a better picture of diabetes care in a state.

国家哲学社会科学文献中心版权所有